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HOLESTEROL IMPORTED VIA endocytosis of low-density lipoproteins (LDLs) has manifold destiny. It can be incorporated into membranes, esterified and stored, or used as substrate for steroid synthesis. The complex mechanism that processes imported cholesterol involves a number of gene products. One that has received recent attention is the Niemann Pick C-1 protein (NPC-1), which comprises 1278 amino acids in its mature form (1) . NPC-1 displays domain homology with the resistance-nodulation-division protein pump family in prokaryotes (2) . The NPC-1 protein is necessary for translocation of cholesterol from the late endosome to other cytoplasmic organelles by a mechanism that has not yet been elucidated (3) . Cells deficient in NPC-1 protein accumulate LDL-cholesterol in the late endosomes and lysosomes as well as in the trans-Golgi network (4) . NPC-1 deficiency is further manifested in delayed (5) and defective (6) movement of cholesterol to and from the plasma membrane, perturbation of intracellular cholesterol homeostasis, and consequent overexpression of cholesterol synthetic enzymes, such as 3-hydroxy-3-methylglutaryl coenzyme A reductase and the LDL receptor (7) .
Two mouse lines that spontaneously display malfunction of NPC-1 have provided important insight into the significance of NPC-1 mutation to sterol metabolism. The BALB/c npc nihϪ/Ϫ mouse has an insertion of intronic sequences and a premature termination sequence with consequent inactivation of the gene (8) . The C57BL/6J spm/spm mouse produces NPC-1 mRNA with an intact coding sequence, with apparent mutations of the 3Ј-untranslated region resulting in expression of different forms (truncated and spliced) and reduced persistence of the cognate mRNA (Gé vry, N. Y., and B. D. Murphy, unpublished data). NPC-1 mutations profoundly affect steroid synthetic organs, including the adrenals (9, 10) and Leydig cells (11) . In the latter cells, there is evidence for hypertrophied endoplasmic reticulum, and a reduction in stored lipid, reduced circulating androgens resulting from compromised steroidogenesis (11) . The consequences include effects on secondary sex characteristics and deficient expression of renal and hepatic proteins (11) .
Although it is known that females of both the BALB/c npc nihϪ/Ϫ and the C57BL/6J spm/spm strains are infertile, there is little information on mechanisms of endocrine disruption that occur in NPC-1 gene mutation in humans or in either mouse model. We therefore undertook a comprehensive analysis of the pituitary-ovarian axis in the BALB/c npc nihϪ/Ϫ model to establish the role of this protein in the reproductive process and to establish the mechanisms of infertility in its absence. We show that there is pituitary and ovarian dysfunction in the NPC-1 mutant mouse caused by the combined effects of alteration in estrogen synthesis and in hypophysial hormone secretion.
RESULTS

BALB/c npc nih؊/؊ Females Are Infertile
The homozygous NPC-1 mutant mice were identified by the PCR genotype analysis (Fig. 1D ). They had reduced body mass associated with smaller stature and reduced abdominal fat deposits (Fig. 1, A and B) . Gross examination indicated hepatomegaly and associated pale liver, due presumably to lipid accumulation (Fig. 1B ). Ovaries were smaller and the reproductive tract was thinner in mutant relative to wild-type (WT) mice (Fig. 1C) . Daily vaginal smears revealed that WT and NPC-1 heterozygous mice showed regular 4-d estrous cycles, whereas female mice homozygous for NPC-1 mutations displayed no cyclic variation in exfoliated vaginal cells. Three weeks after birth, macroscopic and histological analyses of the ovaries of WT and NPC-1 homozygous mutant mice indicated the presence of primary, secondary, and early antral follicles (Fig. 2, A and B) . Histological observation and numerical analysis indicated no apparent variations relative to ovaries of WT mice (Fig. 2, A and B) . At 7-8 wk, when the WT mice were postpubertal, the BALB/c npc nihϪ/Ϫ mice had ovaries with mean (ϮSEM) weight of 1.1 Ϯ 0.22 mg, compared with 4.76 Ϯ 0.51 mg for the WT (P Ͻ 0.001; Fig. 2, C and D) . Uteri are also significantly thinner compared with the WT (Figs. 1C and 2 , I and J). Homozygous NPC-1 mutant mice displayed antral follicles at 7 wk that were smaller than the largest follicles in the WT mice and there was no evidence of ovulation or formation of corpora lutea (Fig. 2D ). The number of secondary and antral follicles was reduced in the mutant mice relative to WT counterparts. The ovarian follicles and stroma displayed accumulation of lipid in mutant mice, as revealed by oil-red-O staining (Fig.  2G) . The stroma of the mutant ovary contained numerous islands of foamy cells (Fig. 2E) , and electron microscopy revealed that these were comprised of apparently healthy nuclei and extensively vacuolated cytoplasm (Fig. 2F) . Oil red-O staining of frozen sections indicated that these regions were replete with lipid ( Fig. 2H) .
BALB/c npc nihϪ/Ϫ mice had reduced uterine diameter, due to the atrophy of uterine components, the myometrium, endometrial stroma, and the endometrial epithelium (Fig. 2, I and J). Examination of serial sections revealed that reduction in the stroma was accompanied by reduction in the convolution of the uterine glands (data not shown).
To determine the consequences of NPC-1 deficiency on steroidogenesis at the molecular level, we analyzed the abundance of mRNAs encoding cytochrome P450aromatase (Cyp19), the rate-limiting enzyme in estrogen synthesis, and the steroidogenic acute regulatory protein (StAR), a key protein required for synthesis of pregnenolone, a precursor of progesterone. The expression of both was substantially compromised in ovaries of homozygous NPC-1 mutants compared with WT mice (Fig. 2, K and L) . Ovarian content of 17␤-estradiol (E2) ranged from 110-135 pg/ovary in WT mice. Estrogen content was below the sensitivity of the assay (2.0 pg) in all mutant ovaries tested, further demonstrating defective steroidogenesis in the mutant mouse ovary.
Exogenous Gonadotropin Treatment and Ovary Transplantation Restore Ovulation and Corpus Luteum Formation to Homozygous Mutant NPC-1 Mice
The ability of female homozygous mice to respond to exogenous gonadotropic hormones was assessed by injection of equine chorionic gonadotropin (eCG) to induce follicle development followed by human chorionic gonadotropin (hCG) 48 h later to cause ovulation (Fig. 3A) . Gonadotropin treatment induced development of numerous large antral follicles at 48 h in both WT and BALB/c npc nihϪ/Ϫ mutant, but these remained in lower abundance in the mutant. The injection of hCG after eCG treatment induced formation of corpora lutea in both WT and mutant mice (Fig. 3A) . As expected from differences in the numbers of large antral follicles, there were fewer than half the number of corpora lutea in the ovaries of mutant mice. Exogenous gonadotropin treatment restored WT patterns of expression of both StAR and Cyp19 to the ovaries of mutant mice (Fig. 3C) .
To address whether ovarian failure in NPC mutant mice was caused by factors intrinsic or extrinsic to the ovary, we transplanted a single mutant mouse ovary to the kidney capsule of adult ovariectomized WT mice. Vaginal swabs indicated the presence of ovarian cycles in recipient mice within 3 wk of transplants. In ovaries recovered at 6 wk, there was evidence of large antral follicles and numerous corpora lutea, indicating that both preovulatory follicle development and ovulation had occurred beneath the host kidney capsule (Fig. 3B) . Indeed, we found examples of oocytes entrapped in the renal parenchyma adjacent to corpora lutea (Fig. 3B , lower right panel), demonstrating that ovulation had occurred at the transplant site.
Hypophysial Consequences of NPC-1 Mutation
A consistent finding was that the anterior pituitary of the homozygous mutant NPC-1 mice was hypoplastic relative to WT mice (Fig. 4, A and B) . Upon histological analysis, two major differences were noted between mutant and WT pituitaries. The first was the presence of vacuolated cells, suggestive of low rates of feedback control and consequent elevated hormone synthesis and secretion. The second was a dramatic reduction in frequency of acidophilic cells in the mutant mouse, as indicated by classic histological staining (Fig. 4 , C-F). We therefore undertook further analysis to determine the specific modifications in the mutant pituitary. Immunohistochemistry indicated no difference in the abundance of cells containing the glycoprotein hormones, LH, or FSH (Fig. 5A ). The frequency of GH and ACTH-positive cells did not differ between mutant and WT. Semiquantitative RT-PCR demonstrated no difference in abundance of mRNA for FSH, LH, TSH, GH, or the precursor of ACTH, proopiomelanocortin (Fig. 6, A and B) , confirming immunohistochemical observations. GnRH receptor expression, as revealed by RT-PCR, did not differ between WT and mutant mice (Fig. 6A) . LH in serum was substantially elevated in the mutant vs. the WT mouse (Fig. 5B) , whereas serum FSH concentrations were 25% greater in mutant relative to WT mice (Fig. 5C ). These findings are consistent with the view that regulation of pituitary gonadotropins by steroid-negative feedback was compromised in mutant mice.
A striking and consistent difference between the strains of mice was the reduction in the occurrence of prolactin in the pituitaries of mutant mice (Figs. 5A and 7, A vs. B). This result concurred with reduced abundance of pituitary prolactin mRNA (Fig. 6A ) and dramatic reduction in prolactin concentrations in circulation (Fig. 5D ). RT-PCR amplification of the long and short isoforms of the dopamine D2 receptor in pituitaries indicated there was greater expression of both in homozygous mutant mice, with the most substantial increase in the short form (Fig. 6, C and D) . This variation resulted in a profound reduction of the ratio of the long to short isoform in the mutant mouse relative to its WT counterpart (Fig. 6, D and E) .
We hypothesized that the reduction in estrogen synthesis by the ovary was responsible for aberrant expression of prolactin in the pituitary and the reduction in the number and size of ovarian follicles in mutant mice. To address this possibility, mutant animals received implants releasing E2 in a linear profile, beginning on d 28 after birth. Pituitaries collected 4 wk later had a volume consistent with WT animals (Fig. 4G) , with a similar frequency of acidophilic cells (Fig. 4, H  and I ). Immunohistochemical analysis revealed that E2 treatment dramatically increased the cytoplasmic signal for prolactin, well in excess of that present in WT pituitaries (Fig. 7) . Examination of ovarian sections demonstrated the presence of secondary and large antral follicles in the ovaries of E2-treated animals (Fig.  7E) . The large follicles were in greater frequency than found in untreated BALB/c npc nihϪ/Ϫ mice (Fig. 7D ).
DISCUSSION
The findings in the present study provide strong evidence for the view that infertility in the BALB/c npc nihϪ/Ϫ mouse is attributed to failure of maturation of ovarian follicles to the large antral and preovulatory stages. This results in a disruption of the cascade of ovarian and pituitary hormone secretion and prevents normal estrous cycles. Pharmacological doses of exogenous gonadotropins induce the latter stages of folliculogenesis, as well as ovulation and CL formation in mutant mice. Furthermore, transplantation of the ovaries to WT hosts indicated that endogenous gonadotropins secreted by the ovariectomized host were sufficient to induce ovarian cyclicity and ovulation. The BALB/c npc nihϪ/Ϫ pituitary, although hypoplastic, had the potential to express and secrete most of the pituitary hormones. In particular, LH and FSH concentrations in circulation are increased in mutant mice relative to the WT animals. This most likely reflects the response to reduced ovarian-negative feedback and suggests the capability for a normal secretory response. Furthermore, pituitary expression and circulating levels of GH did not differ between the WT and mutant mice.
The major difference between the mutant and WT pituitaries was the reduction in capacity to express prolactin in the former, resulting in low levels of circulating prolactin. We suspected that reduced ovarian estrogen synthesis was the cause, as is known that estrogens acutely stimulate prolactin expression in rodent pituitary (12) and ovariectomy reduces prolactin transcripts by more than 80% in the rat pituitary (13) . Furthermore, in vitro studies have demonstrated that estrogen treatment reduces the overall expression of D2 receptors in the rat pituitary (14) . The pituitary phenotype of the NPC-1 mutant strongly resembles that of a transgenic mouse overexpressing the short form of the D2 receptor developed by Iaccarino et al. (15) in which there was hypoplasia of lactotropes and reduction in circulating prolactin. The ratio of the D2 isoforms directs both lactotrope proliferation and prolactin expression, a ratio favoring the long form causes increase in lactotropes and prolactin secretion, whereas overexpression of the short form has the opposite consequence (15) . Herein we report that the NPC-1 mutation is associated with increases in both forms of the D2 receptor, with a more pronounced increase in the short form and an isoform ratio in favor of the short form. The relative expression of D2 receptor splice variants by lactotropes is estrogen dependent; high concentrations induce predominant expression of the long form (16) levels, whereas low estrogen favors the short form of the D2 receptor (17) . The pronounced reduction in Cyp19 expression by BALB/c npc nihϪ/Ϫ mouse ovaries results in reduced estrogen synthesis and circulation. This estrogen deficiency may increase pituitary D2 receptor numbers and favor the expression of the short form of the receptor with the consequence of lactotrope hypoplasia and reduced prolactin secretion. We endeavored to determine whether E2 could reverse pituitary hypoplasia and prolactin expression in the mutant mouse pituitary. Indeed, pituitary volume was restored by this treatment, and the quantity of prolactin detected in the pituitary by immunohistochemistry was increased by E2 treatment, in excess of that seen in either untreated mutants or WT mice.
Subnormal estrogen synthesis is likewise believed to be the basis for the ovarian component of infertility in BALB/c npc nihϪ/Ϫ mice. Mice with inactivating mutations of Cyp19 display disruption of estrogen synthesis, folliculogenesis, and ovulation (18) , closely resembling the ovarian phenotype of the BALB/c npc nihϪ/Ϫ mutant. Cyp19 knockout results in a moderate elevation in circulating FSH and profound elevation in LH relative to WT animals (18), again highly similar to BALB/c npc nihϪ/Ϫ female mice. The positive feedback effects of estrogen that induce the preovulatory LH surge are compromised in the Cyp19 knockout mouse (18) , and appear likewise absent in the BALB/c npc nihϪ/Ϫ mouse. In the present study, replacement of estrogen in mutant mice by means of a chronic release implant increased both the number and maximal size of antral follicles in BALB/c npcnihϪ/Ϫ mice, providing evidence that reduced estrogen synthesis contributes to the infertile pattern of folliculogenesis in mutant animals.
The NPC-1 protein is essential to normal intracellular trafficking of cholesterol, and its absence has multiple subcellular consequences. The early events have been studied in mutant mouse granulosa cells immortalized by viral transformation (19, 20) , and include a failure in induction of cholesterol esterification, and reduction in transfer of imported cholesterol to the plasma membrane. Later effects have been investigated in the mutant mouse and include increased accumulation of unesterified cholesterol in all tissues, due in part to de novo synthesis of cholesterol that contributes to the intracellular cholesterol load (21) . The causes of reduced estrogen secretion by the granulosa cells of NPC-1 mutant mice are not entirely clear. Key factors necessary for steroidogenesis, including StAR protein and Cyp19, are deficient in the ovary of the mutant mouse and are the most likely proximal factors in the paucity of estrogen synthesis. Nonetheless, these elements can be induced by exogenous gonadotropin treatment in mutant animals. Because there is substantial disruption of androgen production by the testis in male BALB/c npc nihϪ/Ϫ mice (11), a defect in formation of androgen precursors for estrogen synthesis may also be responsible for reduction in estrogen in female BALB/c npc nihϪ/Ϫ mice. It is well known that LH is the principal hormone required for androgen production in ovarian theca cells and is likewise responsible for progesterone secretion in luteal cells. Prolactin induces expression of LH receptors in ovarian follicle cells (22) . Null mutation of the prolactin receptor reduces the number of growing follicles and renders the mouse infertile due to defective luteal progesterone secretion (23) . Thus, absence of prolactin secretion in the BALB/c npc nihϪ/Ϫ mouse attenuates the ovarian response to LH, reducing androgen and estrogen synthesis, thereby preventing the latter stages of folliculogenesis and ovulation. The fact that mice bearing a null mutation of the prolactin receptor can ovulate, albeit at a reduced rate (23) , and that ovulation can be induced by exogenous gonadotropins in the BALB/c npc nihϪ/Ϫ mouse, despite lactotrope hypoplasia, suggests that requirement for prolactin at the ovarian level is not absolute.
Although it is attractive to explain infertility in the BALB/c npc nihϪ/Ϫ mouse by invoking solely pituitary and ovarian effects, it remains possible that neural defects cause or contribute to the problem. Indeed, reversal of sterility in the BALB/c npc nihϪ/Ϫ mouse has been achieved by a strategy that directs transgenic expression of the WT NPC-1 protein primarily to the central nervous system (24) . Neuronal degeneration in the BALB/c npc nihϪ/Ϫ mouse is progressive, and hypothalamic degeneration becomes more pronounced with age (25) . The hypothalamus is the source of the dopamine that normally regulates mammalian prolactin secretion (26) . It is possible that the mutation directly affects the tubulo-infundibular dopaminergic system to alter dopamine release patterns, thereby altering prolactin secretion.
In summary, we show that the BALB/c npc nihϪ/Ϫ mouse is infertile due to a pattern of truncated follicu- logenesis and reduced expression of Cyp19. Follicular development and ovulation can be provoked by treatment with exogenous gonadotropins or by transplantation of the mutant ovary beneath kidney capsules of WT mice. The major pituitary disruption is the reduction in prolactin expression and consequent near elimination of prolactin secretion, and this effect can be reversed by treatment with estrogen.
MATERIALS AND METHODS
Animals
All animal studies were approved by the Comité de dé ontologie de la Faculté de Mé decine Vé té rinaire de l'Université de Montré al, accredited by the Canadian Council on Animal Care. Heterozygote NPC mutant mice (BALB/c npc nihϩ/Ϫ ) were obtained from the colony of Dr. Robert Erickson, maintained at 22 C on a 12-h light, 12-h dark cycle and provided pelleted diet and water ad libitum. Offspring bearing the homozygous genotype for the NPC-1 mutation were identified by PCR analyses of tail DNA using forward (5Ј-GTGCT-GGACAGCCAAGTA-3Ј) and reverse (5Ј-GATGGTCTGT-TCTCCCATG-3Ј) primers (Fig. 1D) . WT, heterozygous, and homozygous mutant mice were subject to daily vaginal cytology analysis for a period of 6 wk. We examined ovaries from prepubertal (3 wk) and adult (8 wk) mice. To determine the ovarian competence, we administered 5 IU of eCG (Sigma, Oakville, Ontario, Canada), ip to mice at 8 wk of age. At 48 h after eCG, they received a bolus of hCG, (5 IU, Sigma) and ovaries were recovered for analysis 16 h later.
Ovarian Transplants
WT adult female BALB/c mice were ovariectomized, and a single ovary from an untreated mutant mouse per recipient was transplanted beneath the kidney capsule. Daily vaginal smears were taken beginning 1 wk after transplantation to establish whether ovarian cycles were occurring in trans- planted ovaries. Mutant ovaries and adjacent renal tissues were recovered for analysis 6 wk after transplantation.
Estrogen Replacement
Pellets containing E2 (0.05 mg/pellet, 60-d linear release), purchased from Innovative Research of America (Sarasota, FL), were implanted into the scapular region of mutant mice on d 28 after birth. Four weeks later, pituitaries and ovaries of recipients were collected for histological and immunohistochemical analysis.
Histology and Immunohistochemistry
Ovaries, uteri, adrenals, and pituitary glands of mutant mice were removed, fixed in 10% formalin at 4 C for 24 h, dehydrated, and embedded in paraffin, and sectioned at 5 m. Standard staining and immunohistochemical analysis of the pituitary tropic hormones were performed employing rabbit polyclonal antibodies against the pituitary hormones, LH, FSH, prolactin, ACTH, GH, and TSH (National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD). The second antibody was labeled with the fluorochrome Cy3 (Jackson ImmunoResearch, West Grove, PA). Control tissues were subjected to the same procedures except that first antibody was replaced with preimmune rabbit serum.
RNA Isolation and Analyses
Tissues were collected in RNA-later solution (QIAGEN, Mississauga, Canada), and total RNA was extracted by homogenization in 300 l of RLT buffer with ␤-mercaptoethanol and with RNA extraction kit (QIAGEN) according to the manufacturer's protocol. Total RNA (250 ng for ovaries and 500 ng pituitary) was reverse-transcribed with the poly-deoxythymidine and SuperScript (Invitrogen Life Technologies, Burlington, Ontario, Canada) at 37 C for 60 min. The cDNA was amplified by standard PCR in the presence of 2 Ci of 
